A reflection of some significant milestones achieved by Santa Cruz County companies in 2023.
Read MoreRealSeq Biosciences, Inc., a company developing RNA fragmentomics as real- time diagnostics for disease, was awarded a grant from the National Human Genome Research Institute (NHGRI) for the development of a new small RNA-seq NGS technology.
Read MoreRealSeq’s RiboMarker TM technology was highlighted at the 66th Annual Valley Fever Meeting.
Read MoreLocal Santa Cruz biotechnology company RealSeq Biosciences develops point-of-need tests to identify neglected diseases and to provide rapid diagnosis for diseases impacting disadvantaged populations.
Read More